Previous close | 1.2600 |
Open | 1.2500 |
Bid | 1.2700 x 800 |
Ask | 1.2800 x 1000 |
Day's range | 1.2500 - 1.3000 |
52-week range | 0.9900 - 2.0400 |
Volume | |
Avg. volume | 175,158 |
Market cap | 67.426M |
Beta (5Y monthly) | 0.87 |
PE ratio (TTM) | 3.26 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Spero Therapeutics, Inc. (NASDAQ:SPRO) Q3 2023 Earnings Call Transcript November 13, 2023 Spero Therapeutics, Inc. beats earnings expectations. Reported EPS is $0.04, expectations were $-0.15. Ted Jenkins: Thank you, operator, and thank you all for participating in today’s conference call. This afternoon, Spero Therapeutics released financial results and provided a pipeline update for the third […]
Spero Therapeutics, Inc. (SPRO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Spero Therapeutics, Inc. (SPRO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).